Light-based monitoring for breast cancer during chemo
Part of Cancer, Skin clinical trials.
This study uses a special light-based device to monitor breast cancer during chemotherapy before surgery. It is for women with HER2-positive or triple-negative breast cancer who are planning chemotherapy first.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older
- You have been diagnosed with invasive breast cancer (HER2-positive or triple-negative) and have not started treatment yet
- Your breast tumor is at least 2 cm in size
- You are planning to receive chemotherapy before surgery
- You have no tattoos on your breasts
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special light-based imaging scan to learn more about breast masses and how tumors may respond to chemotherapy before surgery. The scan is meant to help doctors better characterize tumors and potentially track treatment response.
This trial tests whether a blood test (ctDNA) can help doctors monitor how well chemotherapy before surgery is working in women with HER2-positive breast cancer. It aims to see if changes in the blood can predict treatment success.
This study looks at how breast tissue changes during chemotherapy given before surgery (neoadjuvant therapy). It may help doctors better understand treatment effects by taking special breast measurements.
This study uses a special 3D ultrasound and light-based scan to see if breast cancer is shrinking during chemo or chemoradiation before surgery. It may help doctors tell sooner whether the treatment is working.
This study uses ultrasound imaging to monitor how lymph nodes in the armpit respond to chemotherapy before surgery. The goal is to predict which patients will have a good response to treatment and may need less extensive surgery.
This study uses special ultrasound imaging (and may use MRI results) to look for early signs of how locally advanced breast cancer responds to chemotherapy, with or without radiation. If the imaging changes early, it could help doctors adjust treatment sooner.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.